276 related articles for article (PubMed ID: 25595836)
1. New strategies for targeting matrix metalloproteinases.
Fields GB
Matrix Biol; 2015; 44-46():239-46. PubMed ID: 25595836
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase interactions with collagen and elastin.
Van Doren SR
Matrix Biol; 2015; 44-46():224-31. PubMed ID: 25599938
[TBL] [Abstract][Full Text] [Related]
3. Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.
Ndinguri MW; Bhowmick M; Tokmina-Roszyk D; Robichaud TK; Fields GB
Molecules; 2012 Nov; 17(12):14230-48. PubMed ID: 23201642
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.
Overall CM
Mol Biotechnol; 2002 Sep; 22(1):51-86. PubMed ID: 12353914
[TBL] [Abstract][Full Text] [Related]
5. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
Stawikowski MJ; Stawikowska R; Fields GB
Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
[TBL] [Abstract][Full Text] [Related]
6. Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.
Lauer-Fields JL; Whitehead JK; Li S; Hammer RP; Brew K; Fields GB
J Biol Chem; 2008 Jul; 283(29):20087-95. PubMed ID: 18499673
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
Bhowmick M; Stawikowska R; Tokmina-Roszyk D; Fields GB
Chembiochem; 2015 May; 16(7):1084-92. PubMed ID: 25766890
[TBL] [Abstract][Full Text] [Related]
8. High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.
Lauer-Fields JL; Minond D; Chase PS; Baillargeon PE; Saldanha SA; Stawikowska R; Hodder P; Fields GB
Bioorg Med Chem; 2009 Feb; 17(3):990-1005. PubMed ID: 18358729
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.
Fields GB
Front Immunol; 2019; 10():1278. PubMed ID: 31214203
[TBL] [Abstract][Full Text] [Related]
10. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Visse R; Nagase H; Fields GB
J Biol Chem; 2006 Dec; 281(50):38302-13. PubMed ID: 17065155
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and collagen catabolism.
Lauer-Fields JL; Juska D; Fields GB
Biopolymers; 2002; 66(1):19-32. PubMed ID: 12228918
[TBL] [Abstract][Full Text] [Related]
12. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
[TBL] [Abstract][Full Text] [Related]
13. MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity.
Bhaskaran R; Palmier MO; Lauer-Fields JL; Fields GB; Van Doren SR
J Biol Chem; 2008 Aug; 283(31):21779-88. PubMed ID: 18539597
[TBL] [Abstract][Full Text] [Related]
14. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
Lauer-Fields J; Brew K; Whitehead JK; Li S; Hammer RP; Fields GB
J Am Chem Soc; 2007 Aug; 129(34):10408-17. PubMed ID: 17672455
[TBL] [Abstract][Full Text] [Related]
15. Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of MMP-13 hemopexin domain.
Kothapalli R; Khan AM; Basappa ; Gopalsamy A; Chong YS; Annamalai L
PLoS One; 2010 Aug; 5(8):e12494. PubMed ID: 20824169
[TBL] [Abstract][Full Text] [Related]
16. Collagenolytic Matrix Metalloproteinase Structure-Function Relationships: Insights From Molecular Dynamics Studies.
Karabencheva-Christova TG; Christov CZ; Fields GB
Adv Protein Chem Struct Biol; 2017; 109():1-24. PubMed ID: 28683915
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
Lauer-Fields JL; Tuzinski KA; Shimokawa Ki; Nagase H; Fields GB
J Biol Chem; 2000 May; 275(18):13282-90. PubMed ID: 10788434
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase substrate binding domains, modules and exosites. Overview and experimental strategies.
Overall CM
Methods Mol Biol; 2001; 151():79-120. PubMed ID: 11217327
[No Abstract] [Full Text] [Related]
19. Molecular dynamics simulation study on the interaction of collagen-like peptides with gelatinase-A (MMP-2).
Azhagiya Singam ER; Rajapandian V; Subramanian V
Biopolymers; 2014 Jul; 101(7):779-94. PubMed ID: 24374600
[TBL] [Abstract][Full Text] [Related]
20. Identification of collagen binding domain residues that govern catalytic activities of matrix metalloproteinase-2 (MMP-2).
Mikhailova M; Xu X; Robichaud TK; Pal S; Fields GB; Steffensen B
Matrix Biol; 2012; 31(7-8):380-8. PubMed ID: 23085623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
